ALLISON HELGESON: Open Payments
NPI 1659356004 · LYNCHBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,244 in 20 payments from 12 companies in 2025. Trend: 2023 $684 · 2024 $728 · 2025 $1,244
Food & beverage: $1,244
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $303 |
| Lundbeck LLC | 1 | $121 |
| Novo Nordisk Inc | 1 | $121 |
| Phathom Pharmaceuticals, Inc. | 1 | $113 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $111 |
| Merck Sharp & Dohme LLC | 1 | $110 |
| Dexcom, Inc. | 1 | $93 |
| ARGENX US, INC. | 1 | $88 |
| Novartis Pharmaceuticals Corporation | 4 | $72 |
| AstraZeneca Pharmaceuticals LP | 1 | $51 |
Products named: OTEZLA, VYEPTI, Wegovy, VOQUEZNA, CAPLYTA, CAPVAXIVE, EVENITY, Dexcom G6 Transmitter.
Industry payments across VA — which companies pay providers there.
